Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Or Refractory Non-Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00078858
What this trial is testing

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more
Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00002908
What this trial is testing

Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Study completedNCT03019666
What this trial is testing

Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaDiffuse Large B Cell Lymphoma+5 more
Masonic Cancer Center, University of Minnesota 39
Early research (Phase 1)Ended earlyNCT05994157
What this trial is testing

Phase 1, Open-label, Dose-escalation Trial With CD38-SADA:177 Lu-DOTA Drug Complex in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Non-hodgkin Lymphoma
Y-mAbs Therapeutics 1
Testing effectiveness (Phase 2)Looking for participantsNCT05910801
What this trial is testing

Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Who this might be right for
Recurrent Mantle Cell LymphomaRefractory Mantle Cell Lymphoma
Academic and Community Cancer Research United 100
Early research (Phase 1)Looking for participantsNCT06219356
What this trial is testing

GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas

Who this might be right for
Non-Hodgkin Lymphoma
Hangzhou GluBio Pharmaceutical Co., Ltd. 110
Testing effectiveness (Phase 2)UnknownNCT02981745
What this trial is testing

Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Who this might be right for
Relapsed or Refractory B Cell Non-Hodgkin LymphomaChronic Lymphocytic LeukemiaWaldenstrom's Macroglobulinemia+3 more
Centaurus Biopharma Co., Ltd. 200
Early research (Phase 1)Study completedNCT04136275
What this trial is testing

CAR-37 T Cells in Hematologic Malignancies

Who this might be right for
Hematologic MalignancyLeukemiaLymphoma+3 more
Marcela V. Maus, M.D.,Ph.D. 6
Testing effectiveness (Phase 2)Ended earlyNCT01278615
What this trial is testing

Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Recurrent Adult Diffuse Large Cell Lymphoma
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Study completedNCT02676778
What this trial is testing

Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma

Who this might be right for
Peripheral T-cell LymphomaCutaneous T-cell Lymphoma
Eisai Co., Ltd. 45
Testing effectiveness (Phase 2)Ended earlyNCT00851552
What this trial is testing

Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment

Who this might be right for
Lymphoma
Roswell Park Cancer Institute 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT05583149
What this trial is testing

Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas

Who this might be right for
Refractory Aggressive B-cell LymphomasRefractory B-Cell Non-Hodgkin LymphomaAggressive B-cell NHL+10 more
Patrick C. Johnson, MD 28
Early research (Phase 1)UnknownNCT03060850
What this trial is testing

A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL

Who this might be right for
B-cell Lymphoma
Hangzhou ACEA Pharmaceutical Research Co., Ltd. 184
Testing effectiveness (Phase 2)Study completedNCT00436618
What this trial is testing

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
LeukemiaLymphomaLymphoproliferative Disorder
Mayo Clinic 277
Testing effectiveness (Phase 2)Ended earlyNCT01796470
What this trial is testing

Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaMantle Cell LymphomaDiffuse Large B-cell Lymphoma+1 more
Gilead Sciences 66
Early research (Phase 1)WithdrawnNCT04233697
What this trial is testing

Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell Lymphoma

Who this might be right for
Lymphoma, T-Cell
Columbia University
Testing effectiveness (Phase 2)Study completedNCT03610724
What this trial is testing

Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients

Who this might be right for
Non-Hodgkin Lymphoma
Novartis Pharmaceuticals 34
Testing effectiveness (Phase 2)Study completedNCT02187861
What this trial is testing

A Study Evaluating the Safety and Efficacy of Venetoclax (GDC-0199) Plus Bendamustine + Rituximab (BR) in Comparison With BR or Venetoclax Plus Rituximab in Participants With Relapsed and Refractory Follicular Non-Hodgkin's Lymphoma (fNHL)

Who this might be right for
Follicular Lymphoma
Hoffmann-La Roche 163
Early research (Phase 1)Study completedNCT03255096
What this trial is testing

Evaluate Safety, Pharmacokinetics, and Clinical Activity of Combination of RO6870810 and Venetoclax, With or Without Rituximab, in Participants With Relapsed/Refractory DLBCL and/or High-Grade B-Cell Lymphoma and/or High Grade B-Cell Lymphoma With MYC and/or BCL2 and/or BCL6

Who this might be right for
Diffuse Large B-cell LymphomaHigh-Grade B-cell Lymphoma
Hoffmann-La Roche 39
Early research (Phase 1)Study completedNCT04434196
What this trial is testing

A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Celgene 16
Next Page